Drawing for SVAR

USPTO serial 79241657

SVAR

Reviewed by CopyMark Law Group

Reg. 5736546Status 708Registered
Filing date
Status date
Registration date
Apr 30, 2019
Examiner
SHEN, ELIZABETH S
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with SVAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maurine Knutsson

Maurine Knutsson Knutsson IP ABNelinsgatan 14Norrkoping, 60345SWEDEN

Goods and services

ClassDescriptionStatusFirst use
001Substances for use in cell-based reporter gene assays, namely, assays for research purposes; reagents for medical research purposes; reagents for research purposes; reagents for industrial purposes, namely, reagents for scientific and research use; reagents for chemical analyses, namely, chemical reagents for non-medical purposes; cells and reagents for scientific and research use in testing of pharmaceutical products; cell culture media for scientific and research use, namely, cell-lines; components for cell-based analyses using optical methods and containing chemical reagents, namely, cells for scientific and research use; chemical preparations for the laboratory and for scientific, diagnostic and analytical purposes, other than for medical or veterinary useACTIVE
005Reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; diagnostic and analytical substances for medical and veterinary purposes, in particular, laboratory diagnostic kits comprised of medical diagnostic reagents, anti-bodies, and immunochemicals for use in disease detection in the area of medical preventionACTIVE
009[ Instruments for use in performing cell-based assays by means of optic detection, namely, optical inspection apparatus; computer software for use in performing optic based biological analysis; computer software for use in performing optic based biological analysis, and for using tools during drug development, clinical diagnosis, clinical monitoring or assay development; computer application software for mobile phones and handheld computers, namely, software for patient monitoring; apparatus for recording, transmission and reproduction of sound and images; blank magnetic data carriers; digital recording media, namely, blank digital storage media ]SECTION 7(e) - CANCELLED
010[ Medical diagnostic apparatus for testing assays; medical equipment, namely, apparatus for analysing blood ]SECTION 71 - CANCELLED
038[ Telecommunication services, namely, transmission of voice, data, graphics, images, audio and video by means of telecommunications networks, wireless communication networks, and the Internet; providing access to portals on the internet ]SECTION 71 - CANCELLED
042Cell-based assay services, namely, custom design and development of cell-based biochemical assays; cell-based assay services, namely, custom design and development of cell-based biochemical assays for use in drug development, clinical diagnosis, clinical monitoring or assay development; medical research; clinical research in the field of drug development, clinical diagnosis, clinical monitoring or assay development; scientific research; research and development in the field of diagnostic preparations; pharmaceutical drug development services; [ conducting clinical trials for others; ] laboratory research and analysis services in the field of drug development, clinical diagnosis, clinical monitoring or assay development; scientific laboratory testing services; [ research in the fields of medicine and data analytics; ] providing scientific diagnostic services for others in the fields of drug development, clinical diagnosis, clinical monitoring or assay development [ ; testing of chemical preparations and cells for diagnostic purposes ]ACTIVE
044Medical testing services relating to measurement and quantification of drug levels and immunogenicity in patient samples for diagnostic or treatment purposes [ ; medical services, namely, treating persons based on laboratory analysis; providing medical support in the nature of medical monitoring of patients receiving medical treatments; medical diagnostic testing services ]ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 17, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 17, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jun 17, 2025C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Jun 16, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 7, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 25, 2025ES75TEAS SECTION 71 & 15 RECEIVED
Jun 5, 2020INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Apr 15, 2020INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 2, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 13, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Aug 26, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB
Aug 26, 2019FIMPFINAL DISPOSITION PROCESSED
Aug 15, 2019LIMELIMITATION FROM THE IB EXAMINED AND ENTERED
Aug 15, 2019COC.CORRECTION UNDER SECTION 7 - PROCESSED
Aug 15, 2019PLGLASSIGNED TO PARALEGAL
Jul 30, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 8, 2019GPNXNOTIFICATION PROCESSED BY IB
Feb 1, 2019LIMGLIMITATION OF GOODS RECEIVED FROM IB
Jan 23, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 23, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 23, 2019NPUBNOTICE OF PUBLICATION
Jan 3, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 29, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 9, 2018RFNTREFUSAL PROCESSED BY IB
Oct 23, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 23, 2018RFRRREFUSAL PROCESSED BY MPU
Oct 12, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 11, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 11, 2018RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Oct 11, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 10, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2018MAFRAPPLICATION FILING RECEIPT MAILED
Oct 3, 2018DOCKASSIGNED TO EXAMINER
Oct 3, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance